Cite
HARVARD Citation
Lupinacci, R. et al. (n.d.). 336 A phase 3, multicenter, randomised, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of v114 in healthy infants (PNEU-PED). Archives of disease in childhood. p. A204. [Online].